
The latest profit was just what the doctor ordered. The post This small cap ASX biotech could double in under a year, Bell Potter says appeared first on The Motley Fool Australia.
Biome Australia Ltd (ASX: BIO) recently reported a record set of first-half results, which caught the attention of the team at Bell Potter, which has put a bullish price target on the ASX biotech.
S… [+2386 chars]









